Reduced nitric oxide reactivity of a new recombinant human hemoglobin attenuates gastric dysmotility

European Journal of Pharmacology

Volumn 363, Issue 2-3, 1998, Pages 175-178

  Hartman, J Craig ^a   Argoudelis, Gayle ^a   Doherty, Daniel ^a   Lemon, Douglas ^a   Gorczynski, Richard ^a  

^a Baxter Hemoglobin Therapeutics Inc   (United States)

Author keywords

Gastrointestinal motility; Hemoglobin; Nitric oxide (NO)

Indexed keywords

HEMOGLOBIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ARTICLE; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH MOTILITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GASTRIC EMPTYING; HEMOGLOBINS; HUMANS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0032545463     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00830-9     Document Type: Article

References (15)

1. Conklin J.L., Murray J., Ledlow A., Clark E., Hayek B., Picken H., Rosenthal G. Effects of recombinant human hemoglobin on motor functions of the opossum esophagus. J. Pharmacol. Exp. 273:1995;762-767.
2. Conover C.D., Lejeune L., Shum K., Shorr R. The influence of polyethylene glycol conjugation on bovine hemoglobin's intrinsic effect on the gastrointestinal system of the rat. Life Sci. 59:1996;1861-1869.
3. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 16:1998;672-676.
4. Doyle M.P., Doherty D.H., Lemon D.D. Heme pocket alterations decrease vasoconstriction induced by recombinant human hemoglobin. FASEB J. 12(4):1998;A83.
5. Droppleman D.A., Gregory R.L., Alphin R.S. A simplified method for assessing drug effects on gastric emptying in rats. J. Pharmacol. Meth. 4:1980;227-230.
6. Eich R.F., Li T., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Mathews A.J., Johnson K.A., Smith R.D., Phillips G.M.J., Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 35:1996;6976-6983.
7. Evelyn K.A., Malloy H.T. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 126:1938;655-662.
8. Guslandi M. Nitric oxide: an ubiquitous actor in the gastrointestinal tract. Dig. Dis. 12:1994;28-36.
9. Looker D., Abbott-Brown D., Cozart P., Durfee S., Hoffman S., Mathews A.J., Miller-Roehrich J., Shoemaker S., Trimble S., Fermi G., Komiyama N.H., Nagai K., Stetler G.L. A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356:1992;258-260.
10. Looker D., Mathews A.J., Neway J.O., Stetler G.L. Expression of recombinant human hemoglobin in Escherichia coli. Methods Enzymol. 231:1994;364-374.
11. O'Kelly T., Brading A., Mortensen N. Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. Gut. 34:1993;689-693.
12. Plourde V., Quintero E., Suto G., Coimbra C., Tache Y. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Eur. J. Pharmacol. 256:1994;125-129.
13. Sanders K.M., Ward S.M. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am. J. Physiol. 262:1992;G379-G392.
14. Tsuchida, E., 1995. Introduction: overview and perspectives. In: Tsuchida, E. (Ed.), Artificial Red Cells: Materials, Performances and Clinical Study as Blood Substitutes. Wiley, New York, NY, pp. 1-20.
15. Viele M.K., Weiskopf R.B., Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology. 86:1997;848-858.